Eden Research plc (LSE:EDEN) — Market Cap & Net Worth
Market Cap & Net Worth: Eden Research plc (EDEN)
Eden Research plc (LSE:EDEN) has a market capitalization of $249.25K (GBX2.05 Billion) as of August 4, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31139 globally and #1001 in its home market, demonstrating a -5.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eden Research plc's stock price GBX2.55 by its total outstanding shares 803362994 (803.36 Million). See reinvestment intensity of Eden Research plc to understand how much of operating cash flow is reinvested back into capital assets.
Eden Research plc Market Cap History: 2015 to 2026
Eden Research plc's market capitalization history from 2015 to 2026. Data shows change from $1.60 Million to $249.25K (-15.12% CAGR).
Index Memberships
Eden Research plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$912.93 Million | 0.03% | #274 of 722 |
Weight: Eden Research plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Eden Research plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eden Research plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.09x
Eden Research plc's market cap is 0.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.60 Million | $883.31K | -$1.16 Million | 1.81x | N/A |
| 2016 | $1.12 Million | $391.96K | -$1.83 Million | 2.86x | N/A |
| 2017 | $829.56K | $1.88 Million | -$639.09K | 0.44x | N/A |
| 2018 | $1.22 Million | $2.77 Million | -$334.95K | 0.44x | N/A |
| 2019 | $878.37K | $1.83 Million | -$1.14 Million | 0.48x | N/A |
| 2020 | $1.12 Million | $1.37 Million | -$2.27 Million | 0.82x | N/A |
| 2021 | $742.87K | $1.23 Million | -$2.79 Million | 0.60x | N/A |
| 2022 | $464.29K | $1.83 Million | -$2.24 Million | 0.25x | N/A |
| 2023 | $562.04K | $3.19 Million | -$6.49 Million | 0.18x | N/A |
| 2024 | $386.10K | $4.30 Million | -$1.91 Million | 0.09x | N/A |
Competitor Companies of EDEN by Market Capitalization
Companies near Eden Research plc in the global market cap rankings as of August 4, 2026.
Key companies related to Eden Research plc by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #522 globally with a market cap of $51.14 Billion USD.
- Nutrien Ltd (TO:NTR): Ranked #800 globally with a market cap of $33.60 Billion USD ( CA$46.45 Billion CAD).
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1201 globally with a market cap of $21.22 Billion USD ( CN¥144.99 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1479 globally with a market cap of $16.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #522 | Corteva Inc | NYSE:CTVA | $51.14 Billion | $76.04 |
| #800 | Nutrien Ltd | TO:NTR | $33.60 Billion | CA$96.76 |
| #1201 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $21.22 Billion | CN¥27.40 |
| #1479 | CF Industries Holdings Inc | NYSE:CF | $16.81 Billion | $118.30 |
Eden Research plc Historical Marketcap From 2015 to 2026
Between 2015 and today, Eden Research plc's market cap moved from $1.60 Million to $ 249.25K, with a yearly change of -15.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX249.25K | -3.77% |
| 2025 | GBX259.03K | -32.91% |
| 2024 | GBX386.10K | -31.30% |
| 2023 | GBX562.04K | +21.05% |
| 2022 | GBX464.29K | -37.50% |
| 2021 | GBX742.87K | -33.91% |
| 2020 | GBX1.12 Million | +27.97% |
| 2019 | GBX878.37K | -28.00% |
| 2018 | GBX1.22 Million | +47.06% |
| 2017 | GBX829.56K | -26.09% |
| 2016 | GBX1.12 Million | -29.77% |
| 2015 | GBX1.60 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Eden Research plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $249.25K USD |
| MoneyControl | $249.25K USD |
| MarketWatch | $249.25K USD |
| marketcap.company | $249.25K USD |
| Reuters | $249.25K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Eden Research plc
Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such a… Read more